Castle Biosciences Inc: Form 8-K, filed Jan 9, 2023
Filed with the SEC on Jan 9, 2023 and accepted by EDGAR at Jan 9, 2023, 10:19 ET.
Items reported
- Item 2.02 Results of operations
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001447362-23-000007. Last ingested by Listed: Nov 4, 2026, 17:04 ET. Listed shows no prices and gives no investment advice.